These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 13450738)
1. A contribution to the study of collagen disease and the L.E. phenomenon. SHIPTON EA Med J Aust; 1957 Jun; 44(26):911-5. PubMed ID: 13450738 [No Abstract] [Full Text] [Related]
2. [Clinical aspects of collagen diseases. II. Serological study on collagen diseases, with special reference to disseminated lupus erythematosus]. KOMIYA M Jpn J Med Sci Biol; 1961 Nov; 50():720-30. PubMed ID: 14458125 [No Abstract] [Full Text] [Related]
4. Variations in the morphological patterns of "autoimmune" nuclear fluorescence. BECK JS Lancet; 1961 Jun; 1(7188):1203-5. PubMed ID: 13688397 [No Abstract] [Full Text] [Related]
5. [Titers of C 3 factor of serum complement in various autoimmune diseases]. Lehman C; Andreis M; Bennett L; Godoy G Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016 [No Abstract] [Full Text] [Related]
6. Immunofluorescent detection of antinuclear factor using washed, pooled peripheral human leukocytes. Gibson DC; Quarles JM Am J Clin Pathol; 1969 Apr; 51(4):440-4. PubMed ID: 4886839 [No Abstract] [Full Text] [Related]
7. Topics in clinical medicine. Complement levels in disease. Townes AS Johns Hopkins Med J; 1967 May; 120(5):337-43. PubMed ID: 6024563 [No Abstract] [Full Text] [Related]
9. [Recurrent spontaneous abortions associated with lupus anticoagulant in patients with collagen-vascular diseases]. Ichikawa Y; Takaya M; Nozaki H; Kawada T; Uchiyama M; Shimizu H; Yamauchi K; Moriuchi J; Arimori S Ryumachi; 1985 Apr; 25(2):87-94. PubMed ID: 3929398 [No Abstract] [Full Text] [Related]
10. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases]. Wysocka K; Kiczak J Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659 [No Abstract] [Full Text] [Related]
11. THE COLLAGENOSES: TRANSITIONAL FORMS OF LUPUS ERYTHEMATOSUS, DERMATOMYOSITIS, AND SCLERODERMA. KIERLAND RR Mayo Clin Proc; 1964 Jan; 39():53-9. PubMed ID: 14105415 [No Abstract] [Full Text] [Related]
12. [Immuno-biological studies of collagen diseases with special reference to erythematodes. II. Presence in the blood of the so-called erythrocyte aggregation factor]. RASPONI L Arch Ital Dermatol Sifilogr Venereol; 1957; 29(1):54-67. PubMed ID: 13498974 [No Abstract] [Full Text] [Related]
17. Abnormal structures in circulating lymphocytes from patients with systemic lupus erythematosus and related diseases. Grrimley PM; Decker JL; Michelitch HJ; Frantz MM Arthritis Rheum; 1973; 16(3):313-23. PubMed ID: 4708012 [No Abstract] [Full Text] [Related]
18. Pathogenic role of intravascular coagulation in immune diseases. Papilian M; Purice S; Niţă I; Tanaăseanu S Med Interne; 1977; 15(4):341-7. PubMed ID: 594617 [TBL] [Abstract][Full Text] [Related]
19. [Contribution to the study of blood coagulation changes in some collagen diseases]. GARBIN S; GAROFALO E Riv Anat Patol Oncol; 1959 Mar; 15():xxxiv-xxxix. PubMed ID: 13826381 [No Abstract] [Full Text] [Related]
20. [Autoimmunity phenomena in systemic lupus erythematosus and in other diffuse reactive mesenchymopathies]. Masala C; Pala AM; De Philippis CV Folia Allergol (Roma); 1967; 14(6):607-14. PubMed ID: 5583592 [No Abstract] [Full Text] [Related] [Next] [New Search]